WallStreetZenWallStreetZen

NASDAQ: OPGN
Opgen Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their OPGN stock forecasts and price targets.

Forecast return on equity

Is OPGN forecast to generate an efficient return?

Forecast return on assets

Is OPGN forecast to generate an efficient return on assets?

OPGN revenue forecast

What is OPGN's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$2.6M-15.32%

OPGN vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
OPGN$0.70N/AN/A
AIMD$1.14N/AN/A
HSCS$0.12N/AN/A
BIOL$0.19$0.40+110.53%Buy
BSGM$0.66N/AN/A

Opgen Stock Forecast FAQ

What is OPGN's revenue growth forecast for 2024-2024?

(NASDAQ: OPGN) Opgen's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Opgen's revenue in 2024 is $3,070,233.

In 2024, OPGN is forecast to generate $26,035,162 in revenue, with the lowest revenue forecast at $26,035,162 and the highest revenue forecast at $26,035,162.

If you're new to stock investing, here's how to buy Opgen stock.

What is OPGN's forecast return on assets (ROA) for 2024-2024?

(NASDAQ: OPGN) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 9.13%.

What is OPGN's forecast return on equity (ROE) for 2024-2024?

(NASDAQ: OPGN) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.